July 2019 Issue Table Of Contents
Source: Life Science Leader

From The Editor
Feature Articles
- Bassil Dahiyat’s Two-Decade Biotech Startup Odyssey
- Increasing Diversity Among Leadership And Boards
- Ending Generic Drug Shortages At Hospitals: A Capitalist Goes Nonprofit
Capitol Perspectives
CEO Corner
From Principles and Policy to Execution
Companies To Watch
Industry Research
Inside The Industry
- How To Make Sure Restrictive Covenants Survive A Restructuring
- Success In HIV Treatments Creates Additional Challenges For Drug Developers
- The Many Shades Of VC/Repeat Entrepreneur Relationships
- Using War Games To Predict Competitors’ Moves
- Tackling Cell & Gene Therapy Financing & Manufacturing Challenges
Leadership Lessons
Ask The Board
- What Is Your Opinion On The Present Reimbursement Landscape In U.S. Healthcare?
- How Can We Ensure We Don’t Overburden Patients With Requests For Input Into Our Trial Designs And Disease Burden Questions?
- It Seems The High Cost Of Drug Development Is Unsustainable. Should New Regulatory Pathways Be Considered?
This website uses cookies to ensure you get the best experience on our website. Learn more